The course of HIV-1 infection shows a variety of clinical phenotypes with an important involvement of host factors. We compare host gene expression patterns in CD3+ T cells from two of these phenotypes: long-term non-progressor patients (LTNP) and matched control patients with standard HIV disease progression. Array analysis revealed over-expression of 322 genes in progressors and 136 in LTNP. Up-regulated genes in progressors were mainly implicated in the regulation of DNA replication, cell cycle and DNA damage stimulus and mostly localized into cellular organelles. In contrast, most up-regulated genes in LTNP were located at the plasmatic membrane and involved in cytokine-cytokine receptor interaction, negative control of apoptosis or regulation of actin cytoskeleton. Regarding gene interactions, a higher number of viral genes interacting with cellular factors were seen in progressors. Our study offers new comparative insights related to disease status and can distinguish differentiated patterns of gene expression among clinical phenotypes.
Introduction
The natural course of HIV-1 infection shows variability among infected individuals. The majority of patients develop AIDS within 7-10 years after infection but a small fraction (5%), called long-termnon-progressors (LTNP), stay clinically asymptomatic for years in the absence of antiretroviral therapy (Pantaleo et al., 1995) . The mechanisms contributing to these different phenotypes of viral infection are a primary focus of current research in HIV pathogenesis. Despite great advances in recent years identifying several genetic and viral factors associated with non-progression (Lama and Planelles, 2007; Saksena et al., 2007) , the cause for this lack of progression in many cases remains unclear. There is consensus, however, that is governed by multiple factors resulting from the interaction between HIV and host response to the viral infection. It has been described that HIV-1 infection has dramatic effects on host T cells physiology (Chan et al., 2007) with significant changes in the pattern of cell gene expression. The identification of genes responsible for this non-progression should provide a valuable approach to understand HIV pathogenesis.
New high-throughput techniques, like microarray analysis, allow the management of huge information on gene expression patterns comparing different groups of samples. Using these methods, various studies analysed gene expression profiles in different cell types infected with HIV-1 and using in vitro or in vivo approaches (Giri et al., 2006) . However, very few have monitored gene expression in T cells from patients with different stages of AIDS disease (Hyrcza et al., 2007; Sankaran et al., 2005; Wu et al., 2008) . Most of these later studies have examined limited number of samples for each group of patients (5 or less) and in some cases results oblige to combine similar phenotypes in order to obtain more differently regulated genes (Hyrcza et al., 2007) . Sample size is important to detect not only the largest changes in the levels of gene expression but also more subtle differences with any reliability, and also well define phenotypes are essential to avoid bias in large scale studies. For this reason, we decided to focus our analysis in two well defined different groups of patients with a good sample size in both.
In the current study, we used a well characterized cohort of LTNP established in 1997 at the Hospital Carlos III (Rodes et al., 2004) to compare their gene expression profiles in CD3+ T cells with those in typical progressor HIV-1+ patients. Cells were obtained ex vivo from HIV-1 infected patients presenting these two different clinical phenotypes.
RNA from ex vivo CD3+ T cells was used to obtain gene expression data from Agilent microarrays; witch contained 43,377 probe sets corresponding to approximately 30,000 genes described for whole human genome.
Differences in gene expression were measured with a moderated t-statistic. The t-statistic means have been moderated across genes. To do that, the sample standard deviation is shrunk towards a pooled standard deviation value using empirical Bayes methods. Data are presented as progressors versus LTNP gene expression (t = P-LTNP). The analysis revealed a total of 458 differentially expressed genes between both groups of patients (see Supplementary data). Whereas in the progressors' group 322 genes were up-regulated genes (t = positive value), only 136 were seen in the non-progressors (t = negative value), indicating a higher cell activity in more effective infections and two different patterns of gene expression according to phenotype.
An overlap analysis of these differentially expressed genes found in our study with other reported genome-wide analysis and host factor studies (Brass et al., 2008; König et al., 2008; Zhou et al., 2008; Bushman et al., 2009 ) showed 23 coincident genes (gene symbols: HMGB1, THOC4, SNRPD1, RAD51, RANBP1, SUMO1, FEN1, BAZ2B, TUBB, NUDT1, SNRPA1, GINS4, PLK1, KIAA1012, MND1, PSMC3, YWHAQ, MICB, PRKX, SSR1, BCRA1, UBE2C, ASB1).
Functional analysis
Genes operate with an intricate network of interactions within the cell and in some cases in a redundant manner. Complex traits such HIV infections are starting to be considered from a system biology perspective. To facilitate the understanding of the biological implications of these 458 differential genes, functional analyses using the FATIGO tool from GEPAS (Al-Shahrour et al., 2005 were performed. This tool used gene-ontology and KEGG databases to give an association between each gene and its function. The distribution of any combination of terms between two groups of genes can be simultaneously tested by means of a Fisher's exact test. From this analysis relevant data on location of the up-regulated genes (known as cellular component), parts of different biological processes they are implicated with, molecular functions, or involved metabolic pathways, could be obtained.
Regarding the main localization of differentially expressed genes between LTNP and progressors, we noticed that despite a wide distribution of genes in both groups, up-regulated genes in LTNPs were localized in higher proportion within the plasmatic membrane. These include GPR15, IL-17RA, BMPR2, among others. Otherwise, upregulated genes in progressors were found inside the cell and principally in the nucleus, associated to chromosomes and with intracellular organelles ( Fig. 1a and Table 2 section a). The location determines the cell part activated in each case.
For biological processes, some differences emerged in gene expression between LTNP and progressors that may be relevant to the progression of the infection. Despite up-regulated cell cycle genes present in both groups ( Fig. 1b and Table 2 section b), there was a significant higher number of expressed genes in progressors, where the virus has a fairly high replication. In fact, most of the up-regulated genes in progressors were related to cell cycle, specifically to the mitosis phase, nucleic acid metabolic processes and regulation of cell cycle progression. Furthermore, the remaining up-regulated genes were related to endogenous stimulus response, more specifically DNA damage stimulus and DNA repair. On the other hand, up-regulated genes in LTNPs were mostly associated with other specific functions different than cell cycle. These included cell surface receptor linked signal transduction, actin cytoskeleton organization and biogenesis, as well as negative regulation of apoptosis.
When analysing for molecular function most up-regulated genes were within LTNPs and very few in progressors ( Fig. 1c and Table 2 section c). Functions detected were related to ion binding, transmembrane receptor and G-protein coupled receptor activities. Progressors had only up-regulated the nucleic acid binding function. These results are in agreement with observations above, supporting the idea that in LTNP there was an activation of membrane signalling functions, whereas in progressors prevailed the cellular cycle activities, specifically replication. By the analysis approach we could also say that in LTNP the cellular cycle activities were reduced.
Finally, specific metabolic pathways were analysed using the KEGG database. In LTNPs activated genes were associated to the cytokinecytokine receptor interaction, regulation of actin cytoskeleton and focal adhesion processes whereas genes from progressors were mainly related to cell cycle pathway (Fig. 2) .
In conclusion, we have seen differential characteristic functions (focused in different parts of cellular metabolism) from each group. Mainly, higher signalling between cells seems to be a characteristic pattern for LTNP, more specifically the functions of cytokine-cytokine receptor interaction, negative control of apoptosis or regulation of actin cytoskeleton. Otherwise, in progressors the cellular cycle seems to be more active, with an important role of regulation of DNA replication, cell cycle and DNA damage stimulus.
Interactions
Although biological meanings derived from our analyses are relevant to HIV pathogenesis, in an attempt to further complement these findings we performed an HIV-host interaction analysis. Genes with a significant representation in up-regulated functions within both groups were used to find any reported interaction with HIV-1. In Table 3 the main viral-host interactions are shown. Among LTNPs, tat and env were the main viral genes involved with up-regulated host genes, while in progressors there was a greater range of viral genes involved. In the course of infection, the virus uses the cellular machinery to its benefits across the interaction of viral and host genes. Furthermore, accessory proteins appear to be dedicated to various aspects of evasion from adaptive and innate immunity (Malim and Emerman, 2008) . For this reason, a higher number of viral genes interacting with cellular factors may be a sign of more advance stage of infection. 
Discussion
Previous reports on gene expression in LTNP patients have identified interferon responses as a signature for progression (Hyrcza et al., 2007) and an up-regulation of components of MAPK and cytotoxic pathways in LTNP . However, a clearer picture of the subversion of cell machinery by HIV in LTNP is still needed. The goal of our study was to compare the host-virus interactions between a large series of well defined LTNP with more than 20 years of follow up in some cases and a group of Level 4  membrane  ATP11A, PDPK1, VEZT, SYPL1,  DDEF1, TNFRSF10B, EVI2A, SSR1,  RAB14,SEC23A, GPR15, PIP5K3,  XYLT1, CYSLTR1, AMICA1, ARL6IP5,  IL17RA, SPTLC1, FGFRL1, P2RY5,  RDX, PAG1, MPZL1, HOOK3, DPYD,  IL1RAP, TMEM55A, BMPR2, AFTPH,  TMTC2, PDGFB, C18orf1, EVI2B   33  47.14 BAK1, ITGB1BP1, LAMA5, CBX5, ALS2CR4,  CYP4V2, ZDHHC21, CALM3, PKMYT1, IL12RB1,  TMEFF2, MICB, ARF5, FAM14B, KIRREL2,  ARL6IP1, STOML2, TIMM13, FDXR, COX7C,  TAPBP, TMEM97, CD38, CLDN11 C14orf43, SSBP2, EVI5, VEZT, CHD9,  CENTG3, NPEPPS, TACC1, DCK,  BAZ2B, ARID1A, TLE4, ZNF175,  ZFP1, RCOR1, YTHDC1, RFWD2,  MDFIC, KLHL7, HIPK3, EGLN3   21  42.86 EXO1, CENPN, SUV39H2, SSBP3, FHL2,  HIST3H2BB, CBX5, EZH2, CDCA7, THOC4,  RANBP1, KIAA1967, TPX2, GTF3C4, PPIH, CHEK1,  CDC45L, FEN1, ROD1, CHAF1B, RAD51AP1, GPS1,  FOXM1, MYBL2, ANP32E, PSMC3, NFKBIB,  CASC5, MAD2L1, KIAA0101, HMGN2, CORT,  GINS2, CCNB, TIA1, ORC1L, GINS4, EWSR1,  PPP1CA, E2F7, TIPIN, C16orf33, BRCA1, GMNN,  C6orf173, ORC6L, NUF2, CDC6, DLG7, BUD31,  KIF2C, KHSRP, NUCKS1, H2AFZ, TFDP1, HMGB1,  MIER1, RAD54L, RAD51, NRL, DAZP1, BIRC5,  NUDT21, CDT1, HIST1H4D, NUSAP1, NCAPG,  TIMELESS, SUMO1, HMG1L1, MLF1IP, UBE2N progressors, in an attempt to understand and characterize the factors associated with different stages of disease. To avoid masking effects over gene expression, progressors were also treatment naïve. HIV infection leads to extensive defects in T cells which play an important role in its progression rate (Sodora and Silvestri, 2008) , and although cell populations have been extensively characterized, the genetic bases of interactions in relation to disease progression are still poorly understood. LTNP maintain a highly functional T-cell population compared with the majority of HIV-infected patients (Betts et al., 2006) . By using the total T-cell population (CD3+) in peripheral blood we could obtain a global picture of the differences in interactions between virus and host cells in these two phenotypes. In fact, we detected distinct transcriptional features and 458 highly differential genes between LTNP and progressors. With the GEPAS analysis we identified significantly expressed gene sets to further understand their biological mechanism and relationship within phenotypes. Some of these gene differences were related to characteristic functions involved in DNA replication, cell cycle regulation and apoptosis which have been previously reported in the context of HIV replication (Chun et al., 2003) and progression (Hyrcza et al., 2007; Wu et al., 2008) . However we have found other non-reported pathways overexpressed only in one of the studied phenotypes, such as cytokine-cytokine receptor interaction and regulation of actin cytoskeleton in LTNPs and response to DNA damage stimulus in progressors.
Differential dysregulation of cell cycle pathways between LTNP and progressors
It is known that HIV induces modifications in cell cycle in order to use it for viral replication and proliferation. These changes are generated by virus-host-cell interaction, as reported in recent studies that showed the virus needs around 200 host proteins to develop infection (Brass et al., 2008; König et al., 2008; Zhou et al., 2008; Bushman et al., 2009 ). The relative importance of those proteins taking part in the disease progression has not been defined yet. In our study, we observed up-regulated sets of genes related mainly to the cellular mitosis in patients with an evident progression of the disease. Similar results had been seen in other tissues like GALT, where dysregulation of the cell cycle was observed in mucosa cells of both LTNP and viremic patients (Sankaran et al., 2005) . In our study, however, this cell cycle dysregulation was not evident in LTNP. It seems that in CD3+ T cells the bulk of up-regulated cell cycle genes were skewed towards progressor patients which indicates a more rapid turnover of CD4+ and CD8+ T cells in progressive infection in agreement with the Hyrcza and colleagues study (Hyrcza et al., 2007) .
According to these data, the most advanced stages of the infection were accompanied by a higher cell replication which would lead to disease progression in our control group. A certain replicative state in the cell is necessary for a productive HIV infection. However this persistent turnover would disrupt the immune system organization and loss of targets cells resulting in the advancement of disease (Grossman et al., 2006) . The low cell replication observed in LTNP would benefit those patients with a low frequency of infection and a lesser effect over the immune system function. The virus has a target selectivity (CCR5+ CD4+ memory T cells), and an inappropriate activation state may result in too little expression of CCR5 in cell surface to become infected (Grossman et al., 2006) . Moreover, the proportion of LTNP patients with Delta32 mutation in CCR5 is higher than progressors in our population which may contribute to lower the source of viral production.
Higher number of genes related to response to DNA damage stimulus in progressors vs. LTNP
HIV-1, like other viruses with distinct replication strategies, activates DNA damage response pathways. It seems activation of cellular DNA repair and recombination enzymes is beneficial for viral replication (Sinclair et al., 2006) .
Here we found up-regulated genes in the progressors' group involved in DNA repair and response to DNA damage stimulus, whereas no genes related to this function were up-regulated in LTNPs. Therefore, these signals may correlate with higher replication but the role of them in the viral pathogenesis is not well known.
Recently, it has been shown that DNA repair proteins are necessary to early steps in the virus life cycle (König et al., 2008) ; specifically, cellular DNA repair machinery has been implicated in playing critical roles in viral DNA integration and the completion of viral DNA synthesis after integration (Goff, 2007) . Otherwise, activation of DNA damage response pathways can also promote apoptosis (Sinclair et al., 2006; Corbeil et al., 2001) . In fact, two of the genes obtained from the analysis (GTSE1 and BRCA1) are associated with P53 protein, which is activated in HIV-1-induced apoptosis as shown in a recent in vitro study (Imbeault et al., 2009) . In our study, some genes related to the activation of apoptosis are expressed in progressors but not very strongly. For this reason, DNA repair could indicate here a stabilization of proviral integration more than cellular death.
Increased regulation of actin cytoskeleton in LTNP patients
Host cell microfilament cytoskeleton plays a wide range of roles in HIV-1 infection, including viral entry, reverse transcription, transport to the nucleus, integration and finally a correct budding and release from the cell (Fackler and Krausslich, 2006 between HIV and actin cytoskeleton is only beginning to unravel; polymerization of actin is required for viral binding and entry but inhibits some subsequent steps by acting as a physical barrier for the virus. To overcome this barrier and continue with the viral cycle, a protein known as cofilin is activated to depolymerize actin (Liu et al., 2009; Bukrinsky, 2008) . In our study, we observed a higher expression of genes related to actin cytoskeleton organization and biogenesis in the group of LTNPs, many of them related to phosphorylation of cofilin which renders it inactive and prevents its association with actin. In LTNPs an excess of the G-actin form as a result of low depolymerization could block the virus trafficking through the cell. Normally, the virus is capable to modulate and use the microtubules net for its own ends (Fackler and Krausslich, 2006; Lu et al., 2008) by means of viral proteins such as Nef, Gag or Tat which interact with the cytoskeleton (Campbell et al., 2004; Matarrese and Malorni, 2005; Naghavi and Goff, 2007) . In our group of LTNP both gag-p24 and nef gene sequences were characterized (data no shown) and except for one patient (deleted Nef), the rest carried complete genes with, in appearance, conserved functional domains. However, without functional experiments we cannot discard differences in modulation of actin with respect to Nef or Gag from progressors as well as Tat proteins.
On the other hand, the increase in expression of these genes subsequent to viral infection may be associated with transmembrane events of viral binding and entry and other structural events involved with cellular activation and signalling (Vahey et al., 2002) . When we studied the specific function of most up-regulated genes, we saw they were also associated with adhesion processes, so another explanation for non-progression could be that in these patients there is a higher and better immunological synapsis between antigen specific CD8+ T cells and infected CD4+ T cells due to an adhesion processes and remodelling cytoskeleton take place in the synapsis (Shen et al., 2005) . At this point, we cannot distinguish whether up-regulation of the cytoskeletal proteins in LTNP decants towards a better immune response or maintenance of the physical intracellular barrier.
Up-regulation of genes related to cytokine-cytokine receptor interaction in LTNPs
A successful immune response depends upon the ability of Tlymphocytes to respond to antigenic stimulation by cellular activation. This activation results in a cascade of cytokine secretion, receptor up-regulation, cellular proliferation and development of effector functions (Smith et al., 1980) . In our study, activated cell surface receptors linked to signal transduction are observed in LTNPs. The identified genes included cytokine receptors such as IL17RA, IL1RAP or TNFRSF1 which may be part of a stronger, more preserved and protective immune response in this group of patients. IL-17RA controls the activity of IL-17A which regulates the expansion of Th17 CD4+ cell subset (Wright et al., 2008; Smith et al., 2008) . A recent study found that HIV-1-specific IL-17producing CD4+ T cells were reduced or non-detected in LTNP (Yue et al., 2008) which would support our observation. Also data from our lab show a negative correlation between IL-17RA expression and viral load (unpublished data). Others have seen that the imbalance between Th17 cells with other T cells seems to be predictive of disease progression in SIV infection (Cecchinato et al., 2008; Favre et al., 2009) which points out to the equilibrium between pro-and anti-inflammatory responses as a critical factor to distinguish between pathogenic and non-pathogenic infections. IL-1RAP is essential for IL-33 induced T-cell activation and involved in innate cellular immune responses (Ali et al., 2007) , while TNFRSF1 would be involved in the regulation of apoptosis.
Previously, it was shown that viral suppression in LTNPs may result from efficient maintenance of CD4+ T helper and HIV-1specific CD8+ T-cell responses in both gut-associated lymphoid tissue (GALT) and circulating lymphocyte (Sankaran et al., 2005) . In agreement with this observation, our LTNP patients have activated adhesion molecules and cytokine receptors that could relate to an active immunological synapsis and a more efficient T-cell response respectively. Otherwise, some of these molecules can play other functions related to viral pathogens. An example is Gpr15 (upregulated in LTNP) which has been shown as an active coreceptor for viral entrance of HIV-2 (Blaak et al., 2005) . Some of the patients in our study have 32-bp deletion in the CCR5. The up-regulation of Gpr15 can also compensate for a defective CCR5 although with less efficacy; and which may influence by reducing viral fitness. More studies are needed to confirm this hypothesis.
Differences across patterns of expression for apoptosis
It has been reported that LTNP patients present a low level of apoptosis and a consequent reduced rate of CD4+ loss likely accompanied by low viral burden or by the presence of a defective virus (Franceschi et al., 1997; Kirchhoff et al., 1995) . In our study, both groups have activated genes related to apoptosis and differences between groups did not reach a strong statistical significance. However, different patterns of apoptosis gene expression can be glimpsed with a trend towards inhibition in LTNP and activation in controls; the ratio negative/positive apoptosis regulatory genes were higher in LTNP. On the contrary, progressors presented up-regulated genes like CD38, described to have a strong relationship with activation and cell death. These results are in full accordance with previous studies showing CD38 expression on CD8+ T cells as a marker associated with HIV disease progression (Liu et al., 1997) . In a recent report (Jiao et al., 2008) , the activation level of CD8+ T cells, especially CD38 expression, correlated inversely with CD4+ T cell counts and positively with HIV-1 RNA loads in typical progressors. Activated genes for positive regulation of apoptosis in progressors are in agreement with other activated functions in this group such as cell cycle and DNA replication, which were implicated in several pathways linked with cellular death. T-cell apoptosis is thought to be one strategy by which HIV-1 evades host immune supervision.
Genome-wide analyses are important to enrich the list of factors in the HIV-host interaction in order to identify new candidates for HIV therapeutics. Overall, the results in this study offer new comparative insights related to disease status and can distinguish differentiated patterns of gene expression between HIV + LTNP and progressor patients. The most notable features are the preserved regulation of cytoskeleton and cell signalling functions in LTNP and a profound dysregulation of cell cycle in progressors. Many of the genes identified will further facilitate the understanding of genetic basis of progressive and non-progressive disease.
Materials and methods

Patients
Fifteen LTNPs from the Hospital Carlos III cohort and 15 Progressors were studied. LTNP were defined at the time of cohort inclusion as HIV-1+ individuals with more than 10 years of infection (since diagnosis), CD4 counts above 500 cells/μL and naïve for ART. At the time of microarray analysis all of them had viral loads (VL) under 10,000 copies/mL and three of them were considered "elite controllers" (Deeks and Walker, 2007) . Typical progressor HIV-1+ patients were, at the time of study, drug-naïve individuals with less than 5 years of HIV infection after diagnosis and a CD4 decline higher than 80 cells/μl per year. Two years after sample collection, 13 out of 15 progressors (86%) have initiated HAART therapy. A signed informed consent was obtained from participants in accordance with the hospital's Ethic Committee.
Viral and host genetic analysis
Nef and gag genes from viruses infecting each patient were RT-PCR amplified and sequenced using an ABI 3100 genetic analyzer. Phylogenetic analyses were performed in amplified sequences using phylip package. Presence of Delta-32 mutation in CCR5 gene was analysed by PCR in all patients.
Microarray analysis and statistical analysis
Extended experimental conditions are described in supplementary material. Briefly, PBMC of the HIV-1 infected individuals were obtained and CD3+ cells were isolated from them. The purity of isolated CD3+ cells was measured by flow cytometry and in all instances was above 95%. Purified T cells were lysed and total RNA was extracted, amplified and hybridized to Whole Human Genome Microarray 4 × 44K (G4112F, Agilent Technologies). Data was edited and analysed using R (R Development Core team, 2006) and specific packages of the Bioconductor project. To examine genes that were differentially expressed under different conditions, we used the linear modeling features of the Bioconductor limma package (Smyth, 2005) http://www.bioconductor.org/. This package also uses empirical Bayes methods (Smyth, 2004 ) that permit the use of moderated t statistics, and it also incorporates statistical tools to adjust for the multiplicity of the tests. To test the differences between progressors (P) and non-progressors (NP) subjects, the following linear model was fitted to the data:
where y ij is the observation corresponding to status i on individual j, τ i is the effect of the i th status (P and NP) and e ij is the experimental error, assumed to be independently normally distributed with 0 mean and varianceσ e 2 . The differentially expressed genes due to differences in the status were discovered by establishing the null hypothesis of no differences between status estimates τ i for each gene. With the aim to span a broad number of up-regulated genes within phenotype, a cutoff of 0.15 was established based in the false discovery rate (FDR) (adjusted P value by Benjamini and Hochberg's method (BH)). From differentially expressed genes we studied the biological meaning by GEPAS package (Al-Shahrour et al., 2005 . Interaction analyses between HIV-1 and host genes were done using the HIV-1, Human Protein Interaction database (NCBI) (Fu et al., 2009) .
Supplementary materials related to this article can be found online at doi:10.1016/j.virol.2010.12.037.
